72 related articles for article (PubMed ID: 21843778)
1. Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography.
Eriksson O; Sadeghi A; Carlsson B; Eich T; Lundgren T; Nilsson B; Tötterman T; Korsgren O; Sundin A
Nucl Med Biol; 2011 Aug; 38(6):827-33. PubMed ID: 21843778
[TBL] [Abstract][Full Text] [Related]
2. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
Hart DP; Avivi I; Thomson KJ; Peggs KS; Morris EC; Goldstone AH; Linch DC; Ell PJ; Bomanji JB; Mackinnon S
Br J Haematol; 2005 Mar; 128(6):824-9. PubMed ID: 15755287
[TBL] [Abstract][Full Text] [Related]
3. Novel positron emission tomography/computed tomography of diffuse parenchymal lung disease combining a labeled somatostatin receptor analogue and 2-deoxy-2[18F]fluoro-D-glucose.
Win T; Screaton NJ; Porter J; Endozo R; Wild D; Kayani I; Dickson J; Shortman RI; Reubi JC; Ell PJ; Groves AM
Mol Imaging; 2012 Apr; 11(2):91-8. PubMed ID: 22469237
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of extrapulmonary tuberculosis in (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography: experience from 39 cases].
Liu GC; Gao S; Cai L; Chen QS
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Mar; 35(3):184-8. PubMed ID: 22781150
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
7. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
[TBL] [Abstract][Full Text] [Related]
8. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
[TBL] [Abstract][Full Text] [Related]
9. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
10. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography.
Zhang Y; Thorn S; DaSilva JN; Lamoureux M; DeKemp RA; Beanlands RS; Ruel M; Suuronen EJ
Circ Cardiovasc Imaging; 2008 Nov; 1(3):197-204. PubMed ID: 19808543
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of organ-specific glucose metabolism by ¹⁸F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance.
Cheng C; Nakamura A; Minamimoto R; Shinoda K; Tateishi U; Goto A; Kadowaki T; Terauchi Y; Inoue T
Ann Nucl Med; 2011 Dec; 25(10):755-61. PubMed ID: 21818569
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
[TBL] [Abstract][Full Text] [Related]
13. (18)F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[(18)F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography.
Zhang Y; Dasilva JN; Hadizad T; Thorn S; Kuraitis D; Renaud JM; Ahmadi A; Kordos M; Dekemp RA; Beanlands RS; Suuronen EJ; Ruel M
Cell Transplant; 2012; 21(9):1821-35. PubMed ID: 22469629
[TBL] [Abstract][Full Text] [Related]
14. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
15. PET with 18F-FDG-labeled T lymphocytes for diagnosis of acute rat renal allograft rejection.
Grabner A; Kentrup D; Edemir B; Sirin Y; Pavenstädt H; Schlatter E; Schober O; Schäfers M; Schnöckel U; Reuter S
J Nucl Med; 2013 Jul; 54(7):1147-53. PubMed ID: 23670903
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
17. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
19. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction.
Doyle B; Kemp BJ; Chareonthaitawee P; Reed C; Schmeckpeper J; Sorajja P; Russell S; Araoz P; Riederer SJ; Caplice NM
J Nucl Med; 2007 Oct; 48(10):1708-14. PubMed ID: 17909258
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
